J Hammarsten

Summary

Country: Sweden

Publications

  1. doi request reprint Urological aspects of the metabolic syndrome
    Jan Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Rosenborgsgatan 2, S 652 30 Karlstad, Sweden
    Nat Rev Urol 8:483-94. 2011
  2. doi request reprint A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
    J Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Karlstad, Sweden
    Cancer Epidemiol 34:574-9. 2010
  3. ncbi request reprint Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, Halmstad, Sweden
    Blood Press 13:47-55. 2004
  4. ncbi request reprint Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, SE 30185 Halmstad, Sweden
    Eur J Cancer 41:2887-95. 2005
  5. doi request reprint Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
    J Hammarsten
    Department of Urology, Skaraborg Hospital, Skovde, Sweden
    Prostate Cancer Prostatic Dis 12:160-5. 2009
  6. ncbi request reprint Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Halland, Varberg Hospital, Varberg, Sweden
    Scand J Urol Nephrol 36:330-8. 2002
  7. ncbi request reprint Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    J Hammarsten
    Urological Section, Department of Surgery, Varberg Hospital, Varberg, Sweden
    Eur Urol 39:151-8. 2001
  8. doi request reprint One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 43:199-205. 2009
  9. doi request reprint Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
    Per Olov Hedlund
    Department of Urology, Karolinska University Hospital Solna, Sweden
    Scand J Urol Nephrol 42:220-9. 2008
  10. ncbi request reprint Preoperative skin testing of materials used in surgical procedures
    Rosalie Hammarsten
    Central Operating Department, Varberg Hospital, Sweden
    AORN J 77:762-6, 769-71. 2003

Collaborators

  • Jan Erik Damber
  • C Ohlsson
  • Eberhard Varenhorst
  • J Stranne
  • F Rasmussen
  • Par Stattin
  • U Smith
  • Lena Damber
  • Peter Iversen
  • T L J Tammela
  • Per Olov Hedlund
  • Rosalie Hammarsten
  • Jaakko Permi
  • Einar Brekkan
  • Tapani Liukkonen
  • Mirja Ruutu
  • Sven Olof Andersson
  • Inger Hagerman
  • Susanne Ljungeryd
  • Hans Georg Iversen
  • Risto Salminen
  • Arne Höjsgaard
  • Martti Talja
  • Gudmundur Geirsson
  • Reinhard Stege
  • Ilker Tasdemir
  • Torvald Granfors
  • Torsten Sandin
  • Finn Lundbeck
  • Richard Ideström
  • Anders Ramsing
  • Robert Johansson
  • Lars Adell
  • Rolf Lundgren
  • Ake Pousette
  • Bruno Larsson
  • Hans Hedelin
  • Andrzej Owczarski
  • Valdemar Hvidt
  • Sigmund Vaage
  • Jan Erik Johansson
  • Bo Johan Norlen
  • Henrik Willumsen
  • Ole Srensen
  • Torben Krarup
  • Veli Matti Puolakka
  • Ronnie Olsson
  • Jaakko Salo
  • Jesper Rue Andersen
  • Per Ogreid
  • Ebbe Telhammar
  • Svend Mortensen
  • Sture Carlsson
  • Peter Mogensen
  • Inge Höjgaard
  • Erik Larsen
  • Fredrik Hesselberg
  • Kjell Carlstrom
  • Karsten Vada
  • Carl Johan Ribbegren
  • Martti Nurmi
  • Agneta Ullman
  • Jan Olof Olsson
  • Ib Mikkelsen
  • Ole Steen Nielsen
  • Mauritz Wallden
  • Per Lundmo
  • Lars Häggarth
  • John Farber
  • Curt Erik Nelson
  • Anders Spangberg
  • Antero Halme
  • Svein Haukaas
  • Bengt Andersson
  • Eero Kasinen
  • Sören Mommsen
  • Inger Wall
  • Palle Rosenkilde
  • Jörgen Kvist Kristensen
  • Leif Borck
  • Martti Ala Opas
  • Peter Klarskov
  • Bo Hedberg
  • Jouko Viitanen
  • Björn Kihl
  • Paul Skaarup
  • Stig Susskind
  • Harri Juusela
  • Niels Svolgaard
  • Bengt Lindberg

Detail Information

Publications10

  1. doi request reprint Urological aspects of the metabolic syndrome
    Jan Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Rosenborgsgatan 2, S 652 30 Karlstad, Sweden
    Nat Rev Urol 8:483-94. 2011
    ..Urologists need to be aware of the effect that the metabolic syndrome has on urological disorders and should transfer this knowledge to their patients...
  2. doi request reprint A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
    J Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Karlstad, Sweden
    Cancer Epidemiol 34:574-9. 2010
    ..The present findings also seem to confirm that prostate cancer is a component of the metabolic syndrome. Finally, our data generate the hypothesis that the metabolic syndrome conceals early prostate cancer...
  3. ncbi request reprint Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, Halmstad, Sweden
    Blood Press 13:47-55. 2004
    ....
  4. ncbi request reprint Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, SE 30185 Halmstad, Sweden
    Eur J Cancer 41:2887-95. 2005
    ..Furthermore, our data suggest that the insulin level could be used as a marker of prostate cancer prognosis and tumour aggressiveness, regardless of the patient's prostate cancer stage, cancer grade and PSA level...
  5. doi request reprint Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
    J Hammarsten
    Department of Urology, Skaraborg Hospital, Skovde, Sweden
    Prostate Cancer Prostatic Dis 12:160-5. 2009
    ..Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH...
  6. ncbi request reprint Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Halland, Varberg Hospital, Varberg, Sweden
    Scand J Urol Nephrol 36:330-8. 2002
    ..If the hypothesis is true, men with fast-growing BPH would have a more advanced clinical prostate cancer...
  7. ncbi request reprint Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    J Hammarsten
    Urological Section, Department of Surgery, Varberg Hospital, Varberg, Sweden
    Eur Urol 39:151-8. 2001
    ..To test the hypothesis of hyperinsulinaemia as a causal factor for the development of benign prostatic hyperplasia (BPH)...
  8. doi request reprint One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 43:199-205. 2009
    ..To investigate the prevalence of and restrictions in various parts of daily life due to lower urinary tract symptoms (LUTS) in an unselected Swedish male population...
  9. doi request reprint Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
    Per Olov Hedlund
    Department of Urology, Karolinska University Hospital Solna, Sweden
    Scand J Urol Nephrol 42:220-9. 2008
    ..The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events...
  10. ncbi request reprint Preoperative skin testing of materials used in surgical procedures
    Rosalie Hammarsten
    Central Operating Department, Varberg Hospital, Sweden
    AORN J 77:762-6, 769-71. 2003
    ..Skin reactions after preoperative skin testing occurred in 3% to 50% of patients with atopic or contact eczema, allergy, or asthma in their medical history...